Grace Therapeutics, Inc. (GRCE) — QMA analysis
Sector: Healthcare · Market cap: $51M · Price: $1.93 · Data as of 2026-10-23
Grace Therapeutics, Inc. has a below-average composite score of 42/100, higher score than 44% of 22,734 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Catalysts.
What 8 data layers say about GRCE
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 49/100 |
| Technical trend (TSS) | 42/100 |
| Relative strength (RS) | 24/100 |
| Momentum (USS) | 41/100 |
| Insider activity (IAS) | 48/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 37/100 |
| Analysts / transcripts (ATS) | 86/100 |
| Catalysts (XS) | 19/100 |
What does the QMA model currently show for Grace Therapeutics, Inc.?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
For GRCE the layers diverge — some score high (Analysts / transcripts), others low (Catalysts). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
GRCE insider & smart money activity
Over the recent period we record 17 reported insider purchases and 0 sales for GRCE: only reported purchases, no sales. A description of the data layer, not an instruction.
GRCE seasonality
The historically strong window for GRCE was May 1–28 with a hit rate of 67% and an average move of 1.2% (15 years of history).
Historical data does not guarantee future results.
How GRCE compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for GRCE stock?
42/100 (grade D) as of 2026-10-23, fusing 8 data layers. An analytical score, not advice.
Are insiders buying GRCE stock?
Over the recent period, reported: purchases 17, sales 0 (purchases $616K). Insider activity: only reported purchases, no sales — a description of reported data, not a trade instruction.
Where can I see live GRCE data?
Live GRCE data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Explore more — for free
The GRCE score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full GRCE analysis with all layers and live data? Open GRCE detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]